Related Experiment Videos
Effects of antiepileptic drugs on the developing central nervous system
1Department of Neurology, Yale University School of Medicine, New Haven, Connecticut 06510.
Advances in Neurology
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.
The British journal of dermatology·2017
Skin biopsy utilization and melanoma incidence among Medicare beneficiaries.
The British journal of dermatology·2016
Performance assessment for radiologists interpreting screening mammography.
Statistics in medicine·2006
Metabolic substrates other than glucose support axon function in central white matter.
Journal of neuroscience research·2001
(1R,3S)-1-Aminocyclopentane-1,3-dicarboxylic acid (RS-ACPD) reduces intracellular glutamate levels in astrocytes.
Journal of neurochemistry·2001
Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
Journal of the National Cancer Institute·2001
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Cortical Thickness and White Matter Surface Morphology in Tourette Syndrome: A Cohort Study.
Annals of neurology·2026
Cerebellar cognitive affective syndrome (Schmahmann syndrome) following isolated cerebellar infarction.
Dementia & neuropsychologia·2026
Recurrent Catatonia in the Setting of Sickle Cell Pain Crises: Case Report.
Case reports in psychiatry·2026
Neuroimaging Epicenters as Vulnerable Nodes in Plasma p-tau217/Aβ42-Positive Alzheimer's Disease.
Research (Washington, D.C.)·2026